(Stroke. 2001;32:1271.)
© 2001 American Heart Association, Inc.
Original Contributions |
From the Yale Center for Sleep Medicine, Yale University, New Haven, Conn.
| Abstract |
|---|
|
|
|---|
Summary of ReviewSeveral studies have shown a characteristic circadian rhythmicity in stroke. We have discussed the influence of normal sleep states as well as the effect of sleep-related breathing disorders on cerebral hemodynamics. The hemodynamic, metabolic, and hematologic changes during sleep-related breathing disorders in the form of decreased cerebral perfusion and increased coagulability are possible pathogenetic mechanisms for stroke. There are accumulating lines of evidence that sleep apnea disorder may indeed cause diurnal hypertension. However, the increased risk of stroke in patients with sleep-related breathing disorders appears to be independent of coexisting hypertension; the presence of hypertension would increase the risk even further. Furthermore, several studies have documented high prevalence of sleep apnea disorders in patients with transient ischemic attacks and stroke.
ConclusionsSleep-related breathing disorder appears to contribute as a risk factor for stroke through hemodynamic and hematologic changes. Because of the high prevalence of sleep apnea disorder in this population, patients with transient ischemic attacks and stroke should undergo evaluation for these disorders.
Key Words: cerebrovascular disorders risk factors sleep apnea syndromes snoring stroke
| Introduction |
|---|
|
|
|---|
|
Sleep-related breathing disorders have been recognized as important health problems with high morbidity.8 9 10 11 Sleep-related breathing disorders are composed of habitual snoring, increased upper airway resistance syndrome, periodic breathing, and sleep apnea disorder. Obstructive sleep apnea is defined as cessation of airflow due to collapse of the upper airway for at least 10 seconds. Hypopnea is defined as >50% reduction in air flow rate with >4% oxygen desaturation. Significant sleep apnea disorder is present when there are >5 episodes of apnea or hypopnea per hour of sleep (respiratory disturbance index [RDI]).12 However, a clinically significant condition is considered to be present when there are >10 events of apneas or hypopneas per hour of sleep. Obstructive sleep apnea syndrome is a condition characterized by repetitive obstruction of the upper airway often resulting in oxygen desaturation and arousals from sleep. The majority of patients suffer from excessive daytime sleepiness and tiredness with neuropsychological dysfunction in the form of poor work performance, memory impairment, and, at times, mood disorders.13 14 15 16 Many patients with obstructive sleep apnea disorder suffer from concurrent cardiovascular and cerebrovascular disease.17 18 19 20 21 22 23 Recent clinical studies have shown a strong association between sleep-related breathing disorders and stroke. These studies report high prevalence of obstructive sleep apnea in patients with recent stroke.6 22 24 25 In the United States, the prevalence of obstructive sleep apnea disorder, defined as having >5 respiratory events per hour, has been estimated to be 9% to 15% for men and 4% to 9% for women between the ages of 30 and 60 years.9 Obstructive sleep apnea syndrome is relatively common, affecting 2% to 4% of the adult population.9 26 For approximately 31 million Americans aged 65 years and older, sleep apnea is estimated in >7 million of them, with 46% at a moderate or severe level.27 To place the disorder in perspective, in the adult population sleep apnea is more common than diabetes mellitus and asthma.
In this review we consider the effect of sleep on cerebral hemodynamics in normal individuals and pathogenetic mechanisms involved in compromised cerebral perfusion in patients with sleep-related breathing disorders.
| Cerebral Hemodynamics During Normal Sleep |
|---|
|
|
|---|
| Effect of Aging on Cerebral Blood Flow |
|---|
|
|
|---|
|
| Cerebral Hemodynamics in Sleep-Related Breathing Disorders |
|---|
|
|
|---|
| Snoring and Sleep Apnea as Risk Factors for Stroke |
|---|
|
|
|---|
15.0 events per hour. These data show that the presence of
sleep-related breathing disorder at baseline was predictive of
development of hypertension 4 years later, independent of other
confounding factors. It should be noted from the aforementioned studies
that the risk of stroke from sleep-related breathing disorders is
independent of coexisting hypertension. The presence of hypertension
further enhances the risk.
|
| Increased Prevalence of Sleep Apnea in Patients With Transient Ischemic Attack and Stroke |
|---|
|
|
|---|
|
Regardless of whether sleep apnea disorder precedes or follows a stroke, it is associated with poor functional outcome in survivors and higher mortality after 1 year compared with those patients with stroke but without sleep apnea disorder.24 The high prevalence of sleep apnea disorder and poor functional outcome in stroke should prompt physicians to evaluate patients for underlying sleep-related breathing disorders.
| Mechanisms of Transient Ischemic Attack and Stroke in Sleep-Related Breathing Disorders |
|---|
|
|
|---|
| Evaluation of Sleep-Related Breathing Disorders |
|---|
|
|
|---|
In summary, sleep-related breathing disorders are strongly associated with increased risk of stroke independent of known risk factors. The mechanisms underlying this increased risk of stroke are multifactorial and include reduction in cerebral blood flow, altered cerebral autoregulation, and increased platelet aggregation and plasma fibrinogen level. Since sleep-related breathing disorders are treatable, patients with stroke and transient ischemic attacks should be investigated for these conditions.
| Footnotes |
|---|
Received November 15, 2000; revision received January 18, 2001; accepted March 7, 2001.
| References |
|---|
|
|
|---|
2. National Stroke Association. Cost of stroke. Stroke Clin Updates. 1994;5:912.
3.
Marshall J. Diurnal variation in occurrence of strokes. Stroke. 1977;8:230231.
4. Tsementzis SA, Gill JS, Hitchcock ER, Gill S, Beeves D. Diurnal variation of stroke and activity during the onset of stroke. Neurosurgery. 1985;17:901904.[Medline] [Order article via Infotrieve]
5.
Marler JR, Price TR, Clark GL, Muller JE, Robertson T, Mohr JP, Hier DB, Wolf PA, Caplan LR, Foulkes MA. Morning increase in onset of ischemic stroke. Stroke. 1989;20:473476.
6.
Dyken ME, Somers
VK, Yamada T, Ren ZY, Zimmerman MB. Investigating the relationship
between stroke and obstructive sleep apnea. Stroke. 1996;27:401407.
7. Angoli A, Manfredi M, Mossuto L, Piccinelli A. Rapport entre les rythmes hemeronyctaux de la tension arterielle et sa pathogenie de linsuffisance vasculaire cerebrale. Rev Neurol (Paris). 1975;131:597606.[Medline] [Order article via Infotrieve]
8.
He J, Kryger MH, Zorick FJ, Conway W, Roth T. Mortality and apnea index in obstructive sleep apnea: experience in 385 male patients.
Chest. 1988;94:914.
9.
Young T, Palta M,
Dempsey J, Skatrud J, Weber S, Badr S. The occurrence of
sleep-disordered breathing among middle-aged adults.
N Engl J Med. 1993;328:12301235.
10. National Commission on Sleep Disorders Research. A Report of the National Commission on Sleep Disorders Research: Wake Up America: A National Sleep Alert. Washington, DC: US Government Printing Office; 1995.
11. Redline S, Strohl KP. Recognition and consequences of obstructive sleep apnea hypopnea syndrome. Clin Chest Med. 1998;19:119.[Medline] [Order article via Infotrieve]
12. American Academy of Sleep Medicine Task Force. Sleep-related breathing disorders in adults: recommendations for syndrome definition and measurement techniques in clinical research. Sleep. 1999;22:667689.[Medline] [Order article via Infotrieve]
13. Kales A, Caldwell AB, Cadieux RJ, Vela-Buena A, Ruch LG, Mayes SD. Severe obstructive sleep apnea, II: associated psychological and psychosocial consequences. J Chron Dis. 1985;38:426437.
14. Partlett J, Pitson D, Davies R, Stradling J. Daytime vigilance in patients with obstructive sleep apnoea and after CPAP treatment. Thorax. 1994;49:412. Abstract.
15. Grunstein R, Stenlof K, Hedner J, Sjostrom L. Impact of self-reported sleep-breathing disturbances on psychosocial performance in the Swedish Obese Subjects (SOS) study. Sleep. 1995;18:635643.[Medline] [Order article via Infotrieve]
16. Naegele B, Pepin JL, Levy P, Bonnet C, Pellat J, Feuerstein C. Cognitive executive dysfunction in patients with obstructive sleep apnea syndrome (OSAS) after CPAP. Sleep. 1998;21:392397.[Medline] [Order article via Infotrieve]
17. Koskenvuo M, Kaprio J, Talakivi T, Partinen M, Heikkila K, Sarna S. Snoring as a risk factor for stroke in men. BMJ. 1987;294:1619.
18.
Partinen M,
Guilleminault C. Daytime sleepiness and vascular morbidity at
seven-year follow-up in obstructive sleep apnea patients.
Chest. 1990;97:2732.
19.
Parish M, Shepard
J. Cardiovascular effects of sleep disorders.
Chest. 1990;97:12201226.
20.
Palomaki H.
Snoring and the risk of ischemic brain infarction.
Stroke. 1991;22:10211025.
21. Seppala T, Partinen M, Penttila A, Aspholm R, Tiainen E, Kankianen A. Sudden death and sleeping history among Finish men. J Intern Med. 1991;229:2328.[Medline] [Order article via Infotrieve]
22. Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil. 1995;76:7176.[Medline] [Order article via Infotrieve]
23. Olson LG, King MT, Hensley MJ, Saunders NA. A community study of snoring and sleep-disordered breathing: health outcomes. Am J Respir Crit Care Med. 1995;152:717720.[Abstract]
24.
Good DC, Henkle
JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor
functional outcome after stroke.
Stroke. 1996;27:252259.
25. Bassetti C, Aldrich MS. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1999;22:217223.[Medline] [Order article via Infotrieve]
26.
Ohayon M,
Guilleminault C, Priest R, Caulet M. Snoring and breathing pauses
during sleep: telephone interview survey of a United Kingdom sample.
BMJ. 1997;314:860863.
27. Ancoli-Israel S, Kripke DF, Klauber MR, Fell R, Stepnowsky C, Estline E, Khazeni N, Chinn A. Morbidity, mortality, and sleep-disordered breathing in community dwelling elderly. Sleep. 1996;19:277282.[Medline] [Order article via Infotrieve]
28. Heistad DD, Kontos HA. Cerebral circulation. In: Handbook of Physiology: The Cardiovascular System: Peripheral Circulation and Organ Blood Flow. Vol III. Bethesda, Md: American Physiological Society; 1983:137182.
29. Paulson OB, Strandgaard S, Edvinson L. Cerebral autoregulation. Brain Metab Rev. 1990;2:161192.
30. Busija DW. Cerebral autoregulation. In: Phillips JW, ed. The Regulation of Cerebral Blood Flow. Boca Raton, Fla: CRC Press; 1993:4561.
31. Sakai F, Meyer JS, Karacan I, Derman S, Yamamoto M. Normal human sleep: regional cerebral hemodynamics. Ann Neurol. 1980;7:471478.[Medline] [Order article via Infotrieve]
32. Lenzi P, Zoccoli G, Walker AM, Franzini C. Cerebral blood flow regulation in REM sleep: a model for flow-metabolism coupling. Arch Ital Biol. 1999;137:165179.[Medline] [Order article via Infotrieve]
33. Madsen PL, Holm S, Vorstrup S, Friberg L, Lassen NA, Wildschiodtz G. Human regional cerebral blood flow during rapid-eye-movement sleep. J Cereb Blood Flow Metab. 1991;11:502507.[Medline] [Order article via Infotrieve]
34.
Fischer AQ,
Taormina MA, Akhtar B, Chaudhary BA. The effect of sleep on
intracranial hemodynamics: a transcranial
Doppler study. J Child
Neurol. 1991;6:155158.
35. Madsen PL, Schmidt JF, Holm S, Vorstrup S, Lassen NA, Wildschiodtz G. Cerebral oxygen metabolism and cerebral blood flow in man during light sleep (stage 2). Brain Res. 1991;557:217220.[Medline] [Order article via Infotrieve]
36. Droste DW, Berger W, Schuler E, Krauss JK. Middle cerebral artery blood flow velocity in healthy persons during wakefulness and sleep: a transcranial Doppler study. Sleep. 1993;16:603609.[Medline] [Order article via Infotrieve]
37. Hoshi Y, Mizukami S, Tamura M. Dynamic features of hemodynamic and metabolic changes in the human brain during all-night sleep as revealed by near-infrared spectroscopy. Brain Res. 1994;652:257262.[Medline] [Order article via Infotrieve]
38. Hajak G, Klingelhofer J, Schulz-Varszegi M, Matzander G, Sander D, Conrad B, Ruther E. Relationship between cerebral blood flow velocities and cerebral electrical activity in sleep. Sleep. 1994;17:1119.[Medline] [Order article via Infotrieve]
39. Klingelhofer J, Hajak G, Matzander G, Schulz-Varszegi M, Sander D, Ruther E, Conrad B. Dynamics of cerebral blood flow velocities during normal human sleep. Clin Neurol Neurosurg. 1995;97:142148.[Medline] [Order article via Infotrieve]
40. Madsen PL. Blood flow and oxygen uptake in the human brain during various states of sleep and wakefulness. Acta Neurol Scand Suppl. 1993;148:327.[Medline] [Order article via Infotrieve]
41.
Naritomi H, Meyer
JS, Sakai F, Yamaguchi F, Shaw T. Effects of advancing age on regional
cerebral blood flow: studies in normal subjects and subjects with risk
factors for atherothrombotic stroke. Arch
Neurol. 1979;36:410416.
42.
Melamed E, Lavy
S, Bentin S, Cooper G, Rinot Y. Reduction in regional cerebral blood
flow during normal aging in man.
Stroke. 1980;11:3135.
43.
Hatake K,
Kakishita E, Wakabayashi I, Sakiyama N, Hishida S. Effect of aging on
endothelium-dependent vascular relaxation of isolated
human basilar artery to thrombin and bradykinin.
Stroke. 1990;21:10391043.
44.
Mayhan WG, Faraci
FM, Baumbach GL, Heistad DD. Effect of aging on responses of cerebral
arterioles. Am J Physiol. 1990;258:H1138H1143.
45. Paterno R, Faraci FM, Heistad DD. Age-related changes in release of endothelium-derived relaxing factor from the carotid artery. Stroke. 1994;25:24592462.
46.
Thomas R. The
cardiomyopathy of obstructive sleep apnea.
Ann Intern Med. 1996;125:425.
47. Hataki K, Wakabayashi I, Kakishita E, Hishida S. Effect of aging on contractile response to KCl, norepinephrine and 5-hydroxytryptamine in isolated human basilar artery. Gen Pharmacol. 1992;23:417420.[Medline] [Order article via Infotrieve]
48. Meyer JS, Sakai F, Yamaguchi F, Yamamoto M, Shaw T. Regional changes in cerebral blood flow during standard behavioral activation in patients with disorders of speech and mentation compared to normal volunteers. Brain Lang. 1980;9:6177.[Medline] [Order article via Infotrieve]
49.
Jennum P,
Borgesen SE. Intracranial pressure and obstructive sleep apnea.
Chest. 1989;95:279283.
50.
Fischer AQ,
Chaudhary BA, Taormina MA, Akhtar B. Intracranial
hemodynamics in sleep apnea.
Chest. 1992;102:14021406.
51.
Netzer N, Werner
P, Jochums I, Lehman M, Strohl KP. Blood flow of the middle cerebral
artery with sleep-disordered breathing: correlation with obstructive
hypopneas. Stroke. 1998;29:8793.
52. Loeppky JA, Voyles WF, Eldridge MW, Sikes CW. Sleep apnea and autonomic cerebrovascular dysfunction. Sleep. 1987;10:2534.[Medline] [Order article via Infotrieve]
53. Loeppky JA, Miranda FG, Eldridge MW. Abnormal cerebrovascular responses to CO2 in sleep apnea patients. Sleep. 1984;7:97109.[Medline] [Order article via Infotrieve]
54. Balfors EM, Franklin KA. Impairment of cerebral perfusion during obstructive sleep apneas. Am J Respir Crit Care Med. 1994;150:15871591.[Abstract]
55.
Diomedi M,
Placidi F, Cupini LM, Bernardi G, Silvestrini M. Cerebral
hemodynamic changes in sleep apnea syndrome and effect
of continuous positive airway pressure treatment.
Neurology. 1998;51:10511056.
56.
Hayakawa T,
Terashima M, Kayukawa Y, Ohta T, Okada T. Changes in cerebral
oxygenation and hemodynamics during
obstructive sleep apneas.
Chest. 1996;109:916921.
57. Partinen M, Palomaki H. Snoring and cerebral infarction. Lancet. 1985;2:13251326.[Medline] [Order article via Infotrieve]
58.
Spriggs D, French
J, Murdy J, Curless R, Bates D, James O. Snoring increases the risk of
stroke and adversely affects prognosis.
QJ Med. 1992;83:555562.
59. Neau J, Meurice J, Paquereau J, Chavagnant J, Ingrand P, Gil R. Habitual snoring as a risk factor for brain infarction. Acta Neurol Scand. 1995;92:6368.[Medline] [Order article via Infotrieve]
60. Sacco RL. Risk factors and outcomes for ischemic stroke. Neurology. 1995;45(suppl 1):S10S14.
61. Roux F, DAmbrosio C, Mohsenin V. Sleep-related breathing disorders and cardiovascular disease. Am J Med. 2000;108:396402.[Medline] [Order article via Infotrieve]
62.
Nieto FJ, Young
TB, Lind BK, Shahar E, Samet JM, Redline S, DAgostino RB, Newman AB,
Lebowitz MD, Pickering TG. Association of sleep-disordered breathing,
sleep apnea, and hypertension in a large community-based study: Sleep
Heart Health Study. JAMA. 2000;283:18291836.
63.
Peppard PE, Young
T, Palta M, Skatrud J. Prospective study of the association between
sleep-disordered breathing and hypertension.
N Engl J Med. 2000;342:13781384.
64. Placidi F, Diomedi M, Cupini LM, Bernardi G, Silvestrini M. Impairment of daytime cerebrovascular reactivity in patients with obstructive sleep apnoea syndrome. J Sleep Res. 1998;7:288292.[Medline] [Order article via Infotrieve]
65. Sugita Y, Iijima S, Teshima Y, Shimizu T, Nishimura N, Tsutsumi T, Hayashi H, Kaneda H, Hishikawa Y. Marked episodic elevation of cerebrospinal fluid pressure during nocturnal sleep in patients with sleep apnea hypersomnia syndrome. Electromyogr Clin Neurophysiol. 1985;60:214219.
66.
Klingelhofer J,
Hajak G, Sander D, Schulz-Varszegi M, Ruther E, Conrad B. Assessment of
intracranial hemodynamics in sleep apnea syndrome.
Stroke. 1992;23:14271433.
67. Tofler GH, Brezinski D, Schafer AI, Czeisler CA, Rutherford JD, Willich SN, Gleason RE, Williams GH, Muller JE. Concurrent morning increase in platelet aggregability and the risk of myocardial infarction and sudden cardiac death. N Engl J Med. 1987;316:15141518.[Abstract]
68.
Bokinsky G,
Miller M, Ault K, Husband P, Mitchell J. Spontaneous platelet
activation and aggregation during obstructive sleep apnea and its
response to therapy. Chest. 1995;108:625630.
69. Dimsdale JE, Coy T, Ziegler MG, Ancoli-Israel S, Clausen J. The effect of sleep apnea on plasma and urinary catecholamines. Sleep. 1995;18:377381.[Medline] [Order article via Infotrieve]
70. Muller JE, Stone PH, Turi ZG, Rutherford JD, Czeisler CA, Parker C, Poole WK, Passamani E, Roberts R, Robertson T, et al. Circadian variation in the frequency of onset of acute myocardial infarction. N Engl J Med. 1985;313:13151322.[Abstract]
71.
Muller JE, Ludmer
PL, Willich SN, Tofler GH, Aylmer G, Klangos I, Stone PH. Circadian
variation in the frequency of sudden cardiac death.
Circulation. 1987;75:131138.
72. Wilhelmsen L, Svardsudd K, Korsan-Bengtsen K, Larsson B, Welin L, Tibblin G. Fibrinogen as a risk factor for stroke and myocardial infarction. N Engl J Med. 1984;311:501505.[Abstract]
73.
Kannel WB, Wolf
PA, Castelli WP, DAgostino RB. Fibrinogen and risk of
cardiovascular disease: the Framingham Study.
JAMA. 1987;258:11831186.
74.
Wessendorf TE,
Thilmann AF, Wang Y-M, Schreiber A, Konietzko N, Teschler H. Fibrinogen
levels and obstructive sleep apnea in ischemic stroke.
Am J Respir Crit Care Med. 2000;162:20392042.
75.
DAmbrosio C,
Bowman T, Mohsenin V. Quality of life in patients with obstructive
sleep apnea: effect of nasal continuous positive airway pressure: a
prospective study. Chest. 1999;115:123129.
76. Akashiba T, Kurashina K, Yamamoto H, Horie T. Daytime hypertension and the effects of short-term nasal continuous positive airway pressure treatment in obstructive sleep apnea syndrome. Intern Med. 1995;34:528532.[Medline] [Order article via Infotrieve]
77. Fletcher EC. The relationship between systemic hypertension and obstructive sleep apnea: facts and theory. Am J Med. 1995; 98:118128.
Department of Neurology, Upstate Medical University, State University of New York, Veterans Affairs Medical Center, Syracuse, New York
| Introduction |
|---|
|
|
|---|
The role of disruptive snoring and sleep apnea disorder, or
sleep-disordered breathing (SDB), in circulatory alteration and
vascular injury is a concept of recent
development.R1 Evidence of an
association between SDB and sustained systemic hypertension, has become
available recently. Results from the large community-based Sleep Heart
Health StudyR2 indicate that
there is a dose-response relationship between SDB and hypertension. The
adjusted odds of hypertension increased steadily with apnea-hypopnea
index (AHI) values of 15/h to 20/h and higher measured at home,
surpassing odds ratios of 2 for very high AHI values. In a similar
prospective study of SDB and hypertension, the Wisconsin Sleep Cohort
StudyR3 showed that the odds
ratio for developing hypertension at 4 years for subjects with a
baseline AHI of 5/h to 14.9/h was 2.03, while for subjects with AHI of
15/h the odds ratio was 2.89.
These epidemiological, community-based studies fail to reveal the mechanisms that drive the blood pressure up in patients with significant SDB. Powerful negative intrathoracic pressures generated during the apnea event disturb the hemodynamics of the heart. Arousals at the termination of the apnea episode enhance sympathetic activity, and the repeated occurrence of these changes night after night perpetuates blood pressure elevations. Successful treatment of SDB may reduce systemic hypertension. In an early study,R4 application of nasal continuous positive air pressure (nCPAP) to 14 patients with established SDB reduced the mean blood pressure after 8 weeks of treatment. More recently, Pankow et alR5 showed that after 4 to 6 months of nCPAP treatment, 24-hour blood pressure measurements fell from 142/91 to 134/84 in hypertensive patients.
Hypertension is not the only potential complication of SDB. Netzer et alR6 showed that during the apnea event there is a significant reduction in middle cerebral artery (MCA) blood flow velocity that correlates with the duration of the apnea. Intracranial hemodynamic changes in patients with marginal circulatory reserve may contribute to raise the risk of stroke.
REM sleep is a most vulnerable time of the night for subjects with cardiovascular and cerebrovascular risk factors since cerebral blood flow normally increases and cardiac rhythm variability is at a maximum in this stage. In SDB, REM sleep-related atonia of dilator oropharyngeal muscles and loss of respiratory drive dependency on chemoreceptor reflex activity facilitate prolonged episodes of obstructive apnea. Morbidly obese patients with globular abdomensR7 and a mechanically disadvantaged diaphragm, the only functional respiratory muscle in REM sleep, exhibit very prolonged apnea events during REM sleep. In consequence, the accompanying hypoxemia is more profound and the cardiac rhythm changes more prominent, creating a divorce between an increasing demand and a progressively faltering supply of oxygenated blood flow to the brain. When the cerebral circulation is compromised, regions with poor hemodynamic reserve, particularly borderzone areas and terminal artery territories, will suffer the most damage. Preliminary studies of auditory eventrelated potentials in patients with treated SDBR8 found no improvement in abnormal P3 wave latencies, which suggests that permanent structural changes in the white matter of the hemispheres were likely the result of ischemia.
Several recent studies point out that after acute stroke, patients have a high prevalence of SDB. In the study by Good et al,R9 19% of patients had a mean of >100 desaturation events 13 days after stroke. Follow-up evaluations showed that poor oximetry measures during rehabilitation correlated with worse functional outcome and higher mortality. StudiesR10 R11 R12 have confirmed that poststroke patients have an unexpectedly high prevalence of SDB. All emphasize that the rehabilitation potential and even survival may be compromised, because SDB reduces motivation and decreases cognitive capacity while increasing the risk of recurrent stroke and death.
These considerations would be academic were it not for the well-established fact that SDB is correctable. The application of positive-pressure breathing treatment modalities may reduce the risk of hypertension and stroke in patients with SDB and improve the rehabilitation potential of patients after stroke. However, the results of clinical studies showing that successful correction of SDB in patients at risk of stroke and in poststroke patients will improve functional, neurological, and mortality outcomes are still pending. These are clear research goals for the immediate future.
Received November 15, 2000; revision received January 18, 2001; accepted March 7, 2001.
| References |
|---|
|
|
|---|
2. Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, DAgostino RB, Newman AB, Lebowitz MD, Pickering TG, for the Sleep Heart Health Study. Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. JAMA. 2000;283:18291836.
3. Peppard PE, Young T, Palta M, Skatrud J. Prospective study of the association between sleep-disordered breathing and hypertension. N Engl J Med. 2000;342:13781384.
4. Wilcox I, Grunstein RR, Hedner JA, Doyle J, Collins FL, Fletcher PJ, Kelly DT, Sullivan CE. Effect of nasal CPAP during sleep on 24-hour blood pressure in obstructive sleep apnea. Sleep. 1993;16:539544.[Medline] [Order article via Infotrieve]
5.
Pankow W, Lies A,
Lohmann FW. Sleep-disordered breathing and hypertension.
N Engl J Med. 2000;343:966.
6. Netzer N, Werner P, Jochums I, Lehman M, Strohl KP. Blood flow of the middle cerebral artery with sleep-disordered breathing. Correlation with obstructive hypopneas. Stroke. 1998;29:8793.
7. Culebras A. REM-sleep related diaphragmatic insufficiency. Neurology. 1998;50(Suppl 4):393394.
8. Neau JP, Paquereau J, Meurice JC, Chavagnat JJ, Pinon-Vignaud ML, Vandel B, Recard D, Ingrand P, Gil R. Auditory event-related potentials before and after treatment with nasal continuous positive airway pressure in sleep apnea syndrome. Eur J Neurol. 1996;3:2935.
9. Good DC, Henckle JQ, Gelber D, Welsh J, Verhulst S. Sleep-disordered breathing and poor functional outcome after stroke. Stroke. 1996;27:252259.
10. Dyken ME, Somers VK, Yamada T, Ren XY, Zimmerman B. Investigating the relationship between stroke and obstructive sleep apnea. Stroke. 1996;27:401407.
11. Mohsenin V, Valor R. Sleep apnea in patients with hemispheric stroke. Arch Phys Med Rehabil. 1995;76:7176.
12. Bassetti C, Aldrich M. Sleep apnea in acute cerebrovascular diseases: final report on 128 patients. Sleep. 1998;22:217223.
This article has been cited by other articles:
![]() |
P. Jennum and R. L. Riha Epidemiology of sleep apnoea/hypopnoea syndrome and sleep-disordered breathing Eur. Respir. J., April 1, 2009; 33(4): 907 - 914. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Cooke and J. M. Battagel A thermoplastic mandibular advancement device for the management of non-apnoeic snoring: a randomized controlled trial Eur J Orthod, August 1, 2006; 28(4): 327 - 338. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Martinez-Garcia, R. Galiano-Blancart, J.-J. Soler-Cataluna, L. Cabero-Salt, and P. Roman-Sanchez Improvement in nocturnal disordered breathing after first-ever ischemic stroke: role of Dysphagia. Chest, February 1, 2006; 129(2): 238 - 245. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Joyeux-Faure, F. Stanke-Labesque, B. Lefebvre, P. Beguin, D. Godin-Ribuot, C. Ribuot, S. H. Launois, G. Bessard, and P. Levy Chronic intermittent hypoxia increases infarction in the isolated rat heart J Appl Physiol, May 1, 2005; 98(5): 1691 - 1696. [Abstract] [Full Text] [PDF] |
||||
![]() |
G J Gibson Sleep disordered breathing and the outcome of stroke Thorax, May 1, 2004; 59(5): 361 - 363. [Full Text] [PDF] |
||||
![]() |
D Schlosshan and M W Elliott Sleep * 3: Clinical presentation and diagnosis of the obstructive sleep apnoea hypopnoea syndrome Thorax, April 1, 2004; 59(4): 347 - 352. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. McArdle, R. L. Riha, M. Vennelle, E. L. Coleman, M. S. Dennis, C. P. Warlow, and N. J. Douglas Sleep-Disordered Breathing as a Risk Factor for Cerebrovascular Disease: A Case-Control Study in Patients With Transient Ischemic Attacks Stroke, December 1, 2003; 34(12): 2916 - 2921. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. L. Kwok, D. K. K. Ng, and Y. F. Cheung BP and Arterial Distensibility in Children With Primary Snoring Chest, May 1, 2003; 123(5): 1561 - 1566. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. MOHSENIN, M. T. MOSTOFI, and V. MOHSENIN The role of oral appliances in treating obstructive sleep apnea J Am Dent Assoc, April 1, 2003; 134(4): 442 - 449. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Mar, J.R. Rueda, J. Duran-Cantolla, C. Schechter, and J. Chilcott The cost-effectiveness of nCPAP treatment in patients with moderate-to-severe obstructive sleep apnoea Eur. Respir. J., March 1, 2003; 21(3): 515 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ben-Shlomo and S. Melmed The Role of Pharmacotherapy in Perioperative Management of Patients with Acromegaly J. Clin. Endocrinol. Metab., March 1, 2003; 88(3): 963 - 968. [Full Text] [PDF] |
||||
![]() |
P.M. Turkington, J. Bamford, P. Wanklyn, and M.W. Elliott Prevalence and Predictors of Upper Airway Obstruction in the First 24 Hours After Acute Stroke Stroke, August 1, 2002; 33(8): 2037 - 2042. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Silvestrini, B. Rizzato, F. Placidi, R. Baruffaldi, A. Bianconi, and M. Diomedi Carotid Artery Wall Thickness in Patients With Obstructive Sleep Apnea Syndrome Stroke, July 1, 2002; 33(7): 1782 - 1785. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Stroke Home | Subscriptions | Archives | Feedback | Authors | Help | AHA Journals Home | Search Copyright © 2001 American Heart Association, Inc. All rights reserved. Unauthorized use prohibited. |